One of the premier life sciences practice’s in Brazil, Pinheiro Neto Advogados shaped the domestic life sciences landscape through its new approaches to regulatory issues and the inclusion of biotechnology and biodiversity as part of its service offering. Boasting top-notch regulatory, advisory and transactional skills, the team regularly advises on matters before regulatory agencies, including recalls of products under ANVISA’s regulations and pricing issues, and proceedings (including appeals) before the Drug Market Regulation Chamber (CMED) and MAPA for the drug and food industries. Founder of the practice Angela Kung is a key reference in the market for complex regulatory and transactional work; she assists both established multinational life sciences companies and emerging players in Brazil, covering the pharma, medical devices, health services, biotech , and biodiversity segments. Camila Martino Parise draws on her strong regulatory knowledge to advise companies on the setting up of operations in Brazil. Senior associate Nicole Aun is active in technology transfer projects concerning pharma products, while IP issues affecting pharma companies are handled by associate Laura Oliveira Barboza.

Legal 500 Editorial commentary

Key clients

  • Astrazeneca
  • Gerdau
  • Baush & Lomb
  • Coty
  • Wella
  • Biotronik
  • Mylan
  • Blanver
  • Pfizer
  • Novartis

Lawyers

Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.

Other key lawyers

Angela Kung, Camila Martino Parise, Nicole Aun, Laura Oliveira Barboza, Lucas Alexandre Hoeppers, Anna Luiza Bertin Henrique